National Pharmaceutical Pricing Authority notifies ceiling prices of 33 drugs
- Mulayam asks teaching assistants to vote SP, EC sees a 'violation'
- BJP relents to Chandrababu Naidu's demands, alliance likely to continue
- Azam Khan threatens to move Supreme Court, slams EC's relief to Amit Shah
- PMO defends Manmohan Singh, says GDP has grown three times during UPA rule
- IPL 7: Maxwellâs 43-ball 95 helps KXIP chase 206
The National Pharmaceutical Pricing Authority (NPPA) has notified the ceiling prices of 33 drugs as per the new pharmaceutical pricing policy.
The notification, NPPA officials say, will have only marginal impact on the prices of most of the drugs —1-2 per cent at the most — the only exception being formulations on glipizide, an oral anti-diabetic drug whose prices are likely to reduce by 20 per cent or more.
For monocomponent human insulin, prednisolone acetate ophthalmic (a drop used to treat eye allergies) and ozurdex implant (also used in some eye conditions), all imported items, there would be no change in prices.
- Treasure trove: Amicus points finger at temple ‘highest echelons’
- Ramdev ‘goes live’ on poll funding, Congress hits BJP on black money
- Vishwas, Cong worker booked
- Kanpur’s Muslim vote is for betterment, not to stop BJP
- Don’t name next Army Chief before May 16, BJP tells govt
- ‘Opposition conspiring to kill me’